title: Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
authors.affiliation: Office of Arnold & Porter LLP, Washington, DC, USA.
authors.forename: Katherine
authors.initials: K
authors.lastname: Cohen
authors.forename: Joseph W
authors.initials: JW
authors.lastname: Cormier
authors.forename: Mahnu V
authors.initials: MV
authors.lastname: Davar
mesh_terms: D022126:Access to Information / Q000331:legislation & jurisprudence; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence*; D003132:Commerce; D030881:Disclosure / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D017150:Public Sector; D014481:United States; D014486:United States Food and Drug Administration